Teva Pharmaceutical Industries Ltd. ADR-1.50% $19.99B ...

GSK PLC closed 21.63% short of its 52-week high of £18.24, which the company reached on May 16th.

GSK (GSK) plc announced that the Food and Drug Administration has approved Penmenvy for use in individuals aged 10 through 25 years. The vaccine targets five major serogroups of Neisseria ...

Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.80. The company’s shares opened today at p1,433. ...

GSK's settlement follows a $100 million deal by Sanofi earlier this year, reported by Bloomberg, which settled around 4,000 claims. The French drugmaker had rights to the OTC version of the drug ...

GSK has claimed its second breakthrough designation ... rate – which includes stabilisation of the cancer – of up to 100%. GSK started an international phase 1 trial of the drug last summer.

US regulators have approved a new meningitis vaccine developed by GSK, sparking cautious optimism for the sector in the wake of Donald Trump's election for a second term as President. The Food ...

After hours: 7:53:31 p.m. EST ...